Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Using plants against soils contaminated with arsenic

November 16, 2010 11:34 am | by EurekAlert | News | Comments

(University of Zurich) Two essential genes that control the accumulation and detoxification of arsenic in plant cells have been identified. This discovery is the fruit of an international collaboration involving laboratories in Switzerland, South Korea and the USA. The results presented...

TOPICS:

NIH awards $10 million to advance microneedle patch for flu vaccination

November 16, 2010 10:38 am | by EurekAlert | News | Comments

(Georgia Institute of Technology Research News) The National Institutes of Health has awarded $10 million to advance a technology for the painless, self-administration of flu vaccine using patches containing tiny microneedles that dissolve into the skin.

TOPICS:

Predictive Biosciences renews prostate cancer biomarker deal

November 16, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Lexington molecular diagnostics firm Predictive Biosciences Inc. and Epigenomics AG, a German company focused on cancer treatment, have extended their licensing deal related to a biomarker for prostate cancer.

Advertisement

UMass shares $750K for antimicrobial compounds

November 16, 2010 9:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The University of Massachusetts Amherst and PolyMedix Inc., a Pennsylvania biotechnology firm, have received a Phase 2 Small Business Technology Transfer $750,000 contract from the U.S. Army Research Office for more tests on antimicrobial compounds.

Plures Technologies, Inc. Acquires Advanced MicroSensors, Inc.

November 16, 2010 8:40 am | by I-Micronews | News | Comments

Plures Technologies, Inc. (PTI) is in the final phase of acquiring and recapitalizing Advanced MicroSensors, Incorporated (AMS) an established quality high volume ISO fabrication facility, providing high volume production of micro sensors for ...

New Pfizer academic-industrial program based in Cambridge

November 16, 2010 8:40 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Pharmaceutical giant Pfizer Inc. today has established a new network of academic centers that will serve as a "farm team" for drug development. The Global Centers for Therapeutic Innovation is basing its headquarters in Cambridge and will establish partnerships with academic centers...

Largest Acellular Dermal Allografts for Abdominal Wall Repair Now Available From MTF

November 16, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

EDISON, N.J., Nov. 16, 2010 /- The largest natural allograft available on the market today for hernia and abdominal wall repair has been announced by The Musculoskeletal Transplant Foundation (MTF), the nation's leading provider of allograft tissue. MTF has started distributing 20 cm x 25...

TOPICS:

SuperSonic Imagine Announces That Gordon Waldron Has Been Named Executive Vice President and CFO

November 16, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

AIX-EN-PROVENCE, France, Nov. 16, 2010 /- SuperSonic Imagine, the innovative ultrasound medical imaging company, is pleased to announce Gordon Waldron has been named as Executive Vice President and CFO. As a member of the board of directors, he will be responsible for driving all of...

TOPICS:
Advertisement

PhotoMedex Launches New Patient-Focused XTRAC Laser Website

November 16, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

MONTGOMERYVILLE, Pa., Nov. 16, 2010 /- PhotoMedex, Inc. (Nasdaq: PHMD ), a global skin health medical technology company, announced today the launch of its newly designed and engineered website. The new site, www.XTRACLASER.com , introduces and integrates a strong educational component,...

TOPICS:

Prevention 2010: Interview with Judy E. Garber, M.D., M.P.H.

November 16, 2010 8:37 am | by AACR | News | Comments

Prevention 2010: Interview with Judy E. Garber, M.D., M.P.H., AACR president-elect, senior editor of Cancer Prevention Research, and leader of the center for cancer genetics and prevention at Dana-Farber Cancer Institute

TOPICS:

Graymark Healthcare Reports Q3 Financial Results

November 16, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

OKLAHOMA CITY, Nov. 16, 2010 /- Graymark Healthcare Inc., a NASDAQ-traded company (GRMH), today announced financial results for the quarter ending Sept. 30, 2010, including $5.5 million in sales from continuing operations.   Graymark Healthcare has operated two distinct business...

TOPICS:

Reportlinker Adds Global Blood Glucose Meters and Strips Industry

November 16, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Nov. 16, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Blood Glucose Meters and Strips Industry http://www.reportlinker.com/p098406/Global-Blood-Glucose-Meters-and-Strips-Industry.html This report analyzes the...

TOPICS:

Quest Diagnostics to Speak at the Lazard Capital Markets 7th Annual Healthcare Conference

November 16, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., Nov. 16, 2010 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lazard Capital Markets 7th Annual Healthcare Conference in New York City.  The...

TOPICS:

Federal Register: Guidance for Industry, Mammography Quality Standards Act Inspectors, and Food and Drug Administration Staff; The Mammography Quality Standards Act Final Regu...

November 16, 2010 8:31 am | by U.S. Food & Drug Administration | News | Comments

This document is intended to assist mammography facilities and their personnel in meeting the requirements of the Mammography Quality Standards Act (MQSA) regulations.

TOPICS:

Federal Register: External Defibrillators; Public Workshop

November 16, 2010 8:31 am | by U.S. Food & Drug Administration | News | Comments

The purpose of the public workshop is to share FDA's understanding of the risks and benefits of external defibrillators, to clarify FDA's current expectations for how industry should identify, report, and take action on problems observed with these...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading